The Association of Unreported Sleep Disturbances and Systemic Inflammation: Findings from the 2005-2008 NHANES

Jeff A Dennis, Ahmad Alazzeh, Ann Marie Kumfer, Rebecca McDonald-Thomas, Alan N Peiris, Jeff A Dennis, Ahmad Alazzeh, Ann Marie Kumfer, Rebecca McDonald-Thomas, Alan N Peiris

Abstract

Background/objective: Sleep apnea is associated with elevated inflammatory markers. A subgroup of patients never report sleep disturbances to their physician. The inflammatory status of this subgroup is not known. The present study aims to evaluate two inflammatory markers, C-reactive protein (CRP) and red cell distribution width (RDW), in those with unreported sleep disturbances and compares these findings to those with and without reported sleep disorders. We also investigate the utility of RDW as an inflammatory marker in sleep disorders.

Methods: Sample includes 9,901 noninstitutionalized, civilian, nonpregnant adults from the 2005-2008 National Health and Nutrition Examination Survey, a nationally representative, cross-sectional U.S. study. Sleep questionnaire and laboratory data were used to compare inflammatory markers (CRP and RDW) in five subgroups of individuals: reporting physician-diagnosed sleep apnea, reporting another physician-diagnosed sleep disorder, reported sleep disturbance to physician with no resulting diagnosis, unreported sleep disturbance (poor sleep quality not reported to physician), and no diagnosed sleep disorder or sleep disturbance.

Results: Individuals with unreported sleep disturbance had significantly higher odds of elevated RDW (>13.6%) when compared to those without a sleep disturbance in adjusted models (OR=1.33). Those with unreported sleep disturbance had significantly higher odds of elevated CRP levels (>1 mg/L) than those without sleep disturbances (OR 1.34), although the association was not significant when adjusted for obesity and other controls.

Conclusion: Self-identified unreported sleep disturbances are associated with significantly higher odds of elevated RDW than those without sleep disturbances. RDW may serve as a valuable indicator in identifying individuals at higher risk for sleep apnea and other sleep disorders.

References

    1. Loprinzi P. D., Joyner C. Meeting sleep guidelines is associated with better health-related quality of life and reduced premature all-cause mortality risk. American Journal of Health Promotion. 2018;32(1):68–71. doi: 10.1177/0890117116687459.
    1. Harding S. M. Complications and consequences of obstructive sleep apnea. Current Opinion in Pulmonary Medicine. 2000;6(6):485–489. doi: 10.1097/00063198-200011000-00004.
    1. Young T., Palta M., Dempsey J., Skatrud J., Weber S., Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. The New England Journal of Medicine. 1993;328(17):1230–1235. doi: 10.1056/NEJM199304293281704.
    1. Harvard Medical School Division of Sleep Medicine. The Price of Fatigue: The Surprising Economic Costs of Unmanaged Sleep Apnea. Boston, MA, USA: Harvard Medical School Division of Sleep Medicine; 2018. Available from: .
    1. Nadeem R., Molnar J., Madbouly E. M., et al. Serum inflammatory markers in obstructive sleep apnea: a meta-analysis. Journal of Clinical Sleep Medicine. 2013;9(10):1003–1012. doi: 10.5664/jcsm.3070.
    1. Ridker P. M., Buring J. E., Shih J., Matias M., Hennekens C. H. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation. 1998;98(8):731–733. doi: 10.1161/01.CIR.98.8.731.
    1. Danesh J., Whincup P., Walker M., et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. British Medical Journal. 2000;321(7255):199–204. doi: 10.1136/bmj.321.7255.199.
    1. Thorand B., Löwel H., Schneider A., et al. C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: Results from the MONICA Augsburg Cohort Study, 1984–1998. JAMA Internal Medicine. 2003;163(1):93–99. doi: 10.1001/archinte.163.1.93.
    1. Lippi G., Targher G., Montagnana M., Salvagno G. L., Zoppini G., Guidi G. C. Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Archives of Pathology & Laboratory Medicine. 2009;133(4):628–632.
    1. Veeranna V., Zalawadiya S. K., Panaich S., Patel K. V., Afonso L. Comparative analysis of red cell distribution width and high sensitivity C-reactive protein for coronary heart disease mortality prediction in multi-ethnic population: findings from the 1999–2004 NHANES. International Journal of Cardiology. 2013;168(6):5156–5161. doi: 10.1016/j.ijcard.2013.07.109.
    1. Sökücü S. N., Karasulu L., Dalar L., Seyhan E. C., Altin S. Can red blood cell distribution width predict severity of obstructive sleep apnea syndrome? Journal of Clinical Sleep Medicine. 2012;8(5):521–525. doi: 10.5664/jcsm.2146.
    1. Ozsu S., Abul Y., Gulsoy A., Bulbul Y., Yaman S., Ozlu T. Red cell distribution width in patients with obstructive sleep apnea syndrome. Lung. 2012;190(3):319–326. doi: 10.1007/s00408-012-9376-x.
    1. Feliciano A., Linhas R., Marçôa R., et al. Hematological evaluation in males with obstructive sleep apnea before and after positive airway pressure. Revista Portuguesa de Pneumologia. 2017;23(2):71–78. doi: 10.1016/j.rppnen.2016.12.001.
    1. Baessler A., Nadeem R., Harvey M., et al. Treatment for sleep apnea by continuous positive airway pressure improves levels of inflammatory markers—a meta-analysis. Journal of Inflammation. 2013;10(1):p. 13. doi: 10.1186/1476-9255-10-13.
    1. Kıvanc T., Kulaksızoglu S., Lakadamyalı H., Eyuboglu F. Importance of laboratory parameters in patients with obstructive sleep apnea and their relationship with cardiovascular diseases. Journal of Clinical Laboratory Analysis. 2018;32(1)
    1. Colten H. R., Altevogt B. M. Research I of M (US) C on SM and. Extent and Health Consequences of Chronic Sleep Loss and Sleep Disorders. National Academies Press (US); 2006. Available from:
    1. Bartlett D. J., Marshall N. S., Williams A., Grunstein R. R. Predictors of primary medical care consultation for sleep disorders. Sleep Medicine. 2008;9(8):857–864. doi: 10.1016/j.sleep.2007.09.002.
    1. Jackson M. L., Sztendur E. M., Diamond N. T., Byles J. E., Bruck D. Chronic sleep difficulties in non-depressed young women: A longitudinal population-based investigation. Sleep Medicine. 2015;16(9):1116–1122. doi: 10.1016/j.sleep.2015.05.008.
    1. Liu Y., Zhang J., Lam S. P., et al. Help-seeking behaviors for insomnia in Hong Kong Chinese: A community-based study. Sleep Medicine. 2016;21:106–113. doi: 10.1016/j.sleep.2016.01.006.
    1. Stein M. D., Friedmann P. D. Disturbed sleep and its relationship to alcohol use. Substance Abuse. 2005;26(1):1–13. doi: 10.1300/J465v26n01_01.
    1. Young T., Peppard P. E., Gottlieb D. J. Epidemiology of obstructive sleep apnea: a population health perspective. American Journal of Respiratory and Critical Care Medicine. 2002;165(9):1217–1239. doi: 10.1164/rccm.2109080.
    1. Johnson C. L., Paulose-Ram R., Ogden C. L., et al. National Health and Nutrition Examination Survey: Analytic Guidelines, 1999–2010. Vol. 2. National Center for Health Statistics. Vital Health Stat; 2013.
    1. NHANES. National Health and Nutrition Examination Survey Homepage. Available from:
    1. Liu R., Liu X., Zee P. C., et al. Association between sleep quality and C-reactive protein: results from national health and nutrition examination survey, 2005–2008. PLoS ONE. 2014;9(3) doi: 10.1371/journal.pone.0092607.e92607
    1. Visser M., Bouter L. M., McQuillan G. M., Wener M. H., Harris T. B. Elevated C-reactive protein levels in overweight and obese adults. The Journal of the American Medical Association. 1999;282(22):2131–2135. doi: 10.1001/jama.282.22.2131.
    1. Pinto J. A., Ribeiro D. K., Da Silva Cavallini A. F., Duarte C., Freitas G. S. Comorbidities associated with obstructive sleep apnea: A retrospective study. International Archives of Otorhinolaryngology. 2016;20(2):145–150. doi: 10.1055/s-0036-1579546.
    1. Zalawadiya S. K., Veeranna V., Niraj A., Pradhan J., Afonso L. Red cell distribution width and risk of coronary heart disease events. American Journal of Cardiology. 2010;106(7):988–993. doi: 10.1016/j.amjcard.2010.06.006.
    1. Kroenke K., Spitzer R. L., Williams J. B. W. The PHQ-9: validity of a brief depression severity measure. Journal of General Internal Medicine. 2001;16(9):606–613. doi: 10.1046/j.1525-1497.2001.016009606.x.
    1. Prasad K. C-reactive protein (CRP)-lowering agents. Cardiovascular Drug Reviews. 2006;24(1):33–50. doi: 10.1111/j.1527-3466.2006.00033.x.
    1. Hall M. H., Smagula S. F., Boudreau R. M., et al. Association between sleep duration and mortality is mediated by markers of inflammation and health in older adults: The health, aging and body composition study. SLEEP. 2015;38(2):189–195. doi: 10.5665/sleep.4394.
    1. Mullington J. M., Simpson N. S., Meier-Ewert H. K., Haack M. Sleep loss and inflammation. Best Practice & Research Clinical Endocrinology & Metabolism. 2010;24(5):775–784. doi: 10.1016/j.beem.2010.08.014.
    1. Leproult R., Holmbäck U., van Cauter E. Circadian misalignment augments markers of insulin resistance and inflammation, independently of sleep loss. Diabetes. 2014;63(6):1860–1869. doi: 10.2337/db13-1546.
    1. Minoguchi K., Yokoe T., Tazaki T., et al. Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. American Journal of Respiratory and Critical Care Medicine. 2005;172(5):625–630. doi: 10.1164/rccm.200412-1652OC.
    1. Gunbatar H., Sertogullarindan B., Ekin S., Akdag S., Arisoy A., Sayhan H. The correlation between red blood cell distribution width levels with the severity of obstructive sleep apnea and carotid intima media thickness. Medical Science Monitor. 2014;20:2199–2204. doi: 10.12659/MSM.891001.
    1. Ryan S., Nolan G. M., Hannigan E., Cunningham S., Taylor C., McNicholas W. T. Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity. Thorax. 2007;62(6):509–514. doi: 10.1136/thx.2006.066720.
    1. Sharma S. K., Mishra H. K., Sharma H., et al. Obesity, and not obstructive sleep apnea, is responsible for increased serum hs-CRP levels in patients with sleep-disordered breathing in Delhi. Sleep Medicine. 2008;9(2):149–156. doi: 10.1016/j.sleep.2007.02.004.
    1. Bujak K., Wasilewski J., Osadnik T., et al. The prognostic role of red blood cell distribution width in coronary artery disease: a review of the pathophysiology. Disease Markers. 2015;2015:12. doi: 10.1155/2015/824624.824624
    1. Bozorgi A., Nasab E. M., Khoshnevis M., Dogmehchi E., Hamze G., Goodarzynejad H. Red cell distribution width and severe left ventricular dysfunction in ischemic heart failure. Critical Pathways in Cardiology. 2016;15(4):174–178. doi: 10.1097/HPC.0000000000000094.
    1. Yčas J. W. Toward a blood-borne biomarker of chronic hypoxemia: red cell distribution width and respiratory disease. Advances in Clinical Chemistry. 2017;82:105–197. doi: 10.1016/bs.acc.2017.06.002.
    1. Marshall T. Obstructive sleep apnoea. British Journal of General Practice. 2016;66(645):178.3–179. doi: 10.3399/bjgp16X684493.
    1. Stores G. Clinical diagnosis and misdiagnosis of sleep disorders. Journal of Neurology, Neurosurgery & Psychiatry. 2007;78(12):1293–1297. doi: 10.1136/jnnp.2006.111179.
    1. Dyas J. V., Apekey T. A., Tilling M., Orner R., Middleton H., Siriwardena A. N. Patients' and clinicians' experiences of consultations in primary care for sleep problems and insomnia: A focus group study. British Journal of General Practice. 2010;60(574):e180–e200. doi: 10.3399/bjgp10X484183.
    1. Uemura H. Therapeutic efficacy and anti-inflammatory effect of ramelteon in patients with insomnia associated with lower urinary tract symptoms. Research and Reports in Urology. 2013;8(5):113–119.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj